MAPT and Alzheimer disease: Increased expression of CTSD, as lysosomal protease that degrades both amyloid-beta and tau proteins, is part of an adaptive response to AD-related neurodegenerative pathology (Cataldo et al., 1995; Suire et al., 2020).